Wolfram Ponisch
Leipzig, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study.
Journal: Haematologica
Published: May 17, 2024
Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study.
Journal: Journal of cancer research and clinical oncology
Published: April 04, 2022
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV).
Journal: Journal of cancer research and clinical oncology
Published: September 16, 2020
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
Journal: Journal of cancer research and clinical oncology
Published: April 26, 2017
Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).
Journal: Journal of cancer research and clinical oncology
Published: January 02, 2017
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
Journal: Journal of cancer research and clinical oncology
Published: March 26, 2015
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.
Journal: Journal of cancer research and clinical oncology
Published: May 13, 2014
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.
Journal: Journal of cancer research and clinical oncology
Published: August 29, 2013
Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077.
Journal: British journal of haematology
Published: December 18, 2012
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.
Journal: Journal of cancer research and clinical oncology
Published: September 06, 2012
Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone.
Journal: Journal of cancer research and clinical oncology
Published: January 31, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026